{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:01:53Z","timestamp":1791345713102,"version":"4.3.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T00:00:00Z","timestamp":1563753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T00:00:00Z","timestamp":1563753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2016R1A6A3A04009698"],"award-info":[{"award-number":["NRF-2016R1A6A3A04009698"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2018R1A2A1A05076997"],"award-info":[{"award-number":["NRF-2018R1A2A1A05076997"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2016M3A9B6948342"],"award-info":[{"award-number":["NRF-2016M3A9B6948342"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2017R1A2B3004828"],"award-info":[{"award-number":["NRF-2017R1A2B3004828"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2018M3A9D3079288"],"award-info":[{"award-number":["NRF-2018M3A9D3079288"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["KHIDI-HI14C2640"],"award-info":[{"award-number":["KHIDI-HI14C2640"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    CD160 and BTLA both bind to herpes virus entry mediator. Although a negative regulatory function of BTLA in natural killer T (NKT) cell activation has been reported, whether CD160 is also involved is unclear. By analyzing CD160\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    mice and mixed bone marrow chimeras, we show that CD160 is not essential for NKT cell development. However, CD160\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    mice exhibit severe liver injury after in vivo challenge with \u03b1-galactosylceramide (\u03b1-GalCer). Moreover, CD160\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    mice are more susceptible to Concanavalin A challenge, and display elevated serum AST and ALT levels, hyperactivation of NKT cells, and enhanced IFN-\u03b3, TNF, and IL-4 production. Lastly, inhibition of BTLA by anti-BTLA mAb aggravates \u03b1-GalCer-induced hepatic injury in CD160\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    mice, suggesting that both CD160 and BTLA serve as non-overlapping negative regulators of NKT cells. Our data thus implicate CD160 as a co-inhibitory receptor that delivers antigen-dependent signals in NKT cells to dampen cytokine production during early innate immune activation.\n                  <\/jats:p>","DOI":"10.1038\/s41467-019-10320-y","type":"journal-article","created":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T06:02:40Z","timestamp":1563775360000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["CD160 serves as a negative regulator of NKT cells in acute hepatic injury"],"prefix":"10.1038","volume":"10","author":[{"given":"Tae-Jin","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayoung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeongmin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon Ah","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungtaek","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Hwa","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4809-825X","authenticated-orcid":false,"given":"Yang-Xin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Luisa","family":"Del Rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose-Ignacio","family":"Rodriguez-Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassian","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Suk","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1192-6031","authenticated-orcid":false,"given":"Sang-Jun","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5378-9258","authenticated-orcid":false,"given":"Kyung-Mi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,22]]},"reference":[{"key":"10320_CR1","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.4049\/jimmunol.161.6.2780","volume":"161","author":"A Anumanthan","year":"1998","unstructured":"Anumanthan, A. et al. Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes. J. Immunol. 161, 2780\u20132790 (1998).","journal-title":"J. Immunol."},{"key":"10320_CR2","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1182\/blood-2005-12-019919","volume":"108","author":"P Fons","year":"2006","unstructured":"Fons, P. et al. Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. Blood 108, 2608\u20132615 (2006).","journal-title":"Blood"},{"key":"10320_CR3","doi-asserted-by":"publisher","first-page":"4426","DOI":"10.4049\/jimmunol.175.7.4426","volume":"175","author":"M Maeda","year":"2005","unstructured":"Maeda, M. et al. Murine CD160, Ig-like receptor on NK cells and NKT cells, recognizes classical and nonclassical MHC class I and regulates NK cell activation. J. Immunol. 175, 4426\u20134432 (2005).","journal-title":"J. Immunol."},{"key":"10320_CR4","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1073\/pnas.0409071102","volume":"102","author":"LC Gonzalez","year":"2005","unstructured":"Gonzalez, L. C. et al. A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator. P Natl Acad. Sci. USA 102, 1116\u20131121 (2005).","journal-title":"P Natl Acad. Sci. USA"},{"key":"10320_CR5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/ni1144","volume":"6","author":"JR Sedy","year":"2005","unstructured":"Sedy, J. R. et al. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat. Immunol. 6, 90\u201398 (2005).","journal-title":"Nat. Immunol."},{"key":"10320_CR6","doi-asserted-by":"publisher","first-page":"16535","DOI":"10.1073\/pnas.0909295106","volume":"106","author":"TC Cheung","year":"2009","unstructured":"Cheung, T. C. et al. Unconventional ligand activation of herpesvirus entry mediator signals cell survival (vol 106, pg 6244, 2009). Proc Natl Acad. Sci. USA 106, 16535\u201316536 (2009).","journal-title":"Proc Natl Acad. Sci. USA"},{"key":"10320_CR7","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.4049\/jimmunol.161.4.1786","volume":"161","author":"JA Harrop","year":"1998","unstructured":"Harrop, J. A. et al. Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines. J. Immunol. 161, 1786\u20131794 (1998).","journal-title":"J. Immunol."},{"key":"10320_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/73136","volume":"6","author":"K Tamada","year":"2000","unstructured":"Tamada, K. et al. Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway. Nat. Med. 6, 283\u2013289 (2000).","journal-title":"Nat. Med."},{"key":"10320_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ni.1679","volume":"10","author":"SD Blackburn","year":"2009","unstructured":"Blackburn, S. D. et al. Coregulation of CD8(+) T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat. Immunol. 10, 29\u201337 (2009).","journal-title":"Nat. Immunol."},{"issue":"8","key":"10320_CR10","doi-asserted-by":"publisher","first-page":"e1002840","DOI":"10.1371\/journal.ppat.1002840","volume":"8","author":"Yoav Peretz","year":"2012","unstructured":"Peretz Y. et al. CD160 and PD-1 co-expression on HIV-specific CD8 T cells defines a subset with advanced dysfunction. PLos Pathog. 8, e1002840 (2012).","journal-title":"PLoS Pathogens"},{"issue":"9","key":"10320_CR11","doi-asserted-by":"publisher","first-page":"e1004380","DOI":"10.1371\/journal.ppat.1004380","volume":"10","author":"Selena Vigan\u00f2","year":"2014","unstructured":"Vigano S. et al. CD160-associated CD8 T-cell functional impairment is independent of PD-1 expression. PLos Pathog. 10, e1004380 (2014).","journal-title":"PLoS Pathogens"},{"key":"10320_CR12","doi-asserted-by":"publisher","first-page":"16963","DOI":"10.1073\/pnas.012681099","volume":"99","author":"P Le Bouteiller","year":"2002","unstructured":"Le Bouteiller, P. et al. Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity. Proc. Natl Acad. Sci. USA 99, 16963\u201316968 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10320_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/353068a0","volume":"353","author":"A Bendelac","year":"1991","unstructured":"Bendelac, A. & Schwartz, R. H. CD4+ and CD8+ T cells acquire specific lymphokine secretion potentials during thymic maturation. Nature 353, 68\u201371 (1991).","journal-title":"Nature"},{"key":"10320_CR14","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nri1309","volume":"4","author":"DI Godfrey","year":"2004","unstructured":"Godfrey, D. I., MacDonald, H. R., Kronenberg, M., Smyth, M. J. & Van Kaer, L. NKT cells: what\u2019s in a name? Nat. Rev. Immunol. 4, 231\u2013237 (2004).","journal-title":"Nat. Rev. Immunol."},{"key":"10320_CR15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1146\/annurev.immunol.25.022106.141711","volume":"25","author":"A Bendelac","year":"2007","unstructured":"Bendelac, A., Savage, P. B. & Teyton, L. The biology of NKT cells. Annu Rev. Immunol. 25, 297\u2013336 (2007).","journal-title":"Annu Rev. Immunol."},{"key":"10320_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nri1531","volume":"5","author":"L Van Kaer","year":"2005","unstructured":"Van Kaer, L. \u03b1-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles. Nat. Rev. Immunol. 5, 31\u201342 (2005).","journal-title":"Nat. Rev. Immunol."},{"key":"10320_CR17","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1084\/jem.188.8.1521","volume":"188","author":"L Brossay","year":"1998","unstructured":"Brossay, L. et al. CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 188, 1521\u20131528 (1998).","journal-title":"J. Exp. Med"},{"key":"10320_CR18","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1126\/science.278.5343.1626","volume":"278","author":"T Kawano","year":"1997","unstructured":"Kawano, T. et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278, 1626\u20131629 (1997).","journal-title":"Science"},{"key":"10320_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/nprot.2007.515","volume":"3","author":"H Watarai","year":"2008","unstructured":"Watarai, H., Nakagawa, R., Omori-Miyake, M., Dashtsoodol, N. & Taniguchi, M. Methods for detection, isolation and culture of mouse and human invariant NKT cells. Nat. Protoc. 3, 70\u201378 (2008).","journal-title":"Nat. Protoc."},{"key":"10320_CR20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/ni.1841","volume":"11","author":"DI Godfrey","year":"2010","unstructured":"Godfrey, D. I., Stankovic, S. & Baxter, A. G. Raising the NKT cell family. Nat. Immunol. 11, 197\u2013206 (2010).","journal-title":"Nat. Immunol."},{"key":"10320_CR21","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.immuni.2008.07.011","volume":"29","author":"AK Savage","year":"2008","unstructured":"Savage, A. K. et al. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 29, 391\u2013403 (2008).","journal-title":"Immunity"},{"key":"10320_CR22","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/ni.2731","volume":"14","author":"YJ Lee","year":"2013","unstructured":"Lee, Y. J., Holzapfel, K. L., Zhu, J., Jameson, S. C. & Hogquist, K. A. Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells. Nat. Immunol. 14, 1146\u20131154 (2013).","journal-title":"Nat. Immunol."},{"key":"10320_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1365-2567.2011.03405.x","volume":"133","author":"H Matsumoto","year":"2011","unstructured":"Matsumoto, H. et al. Coincidence of autoantibody production with the activation of natural killer T cells in alpha-galactosylceramide-mediated hepatic injury. Immunology 133, 21\u201328 (2011).","journal-title":"Immunology"},{"key":"10320_CR24","doi-asserted-by":"publisher","first-page":"8816","DOI":"10.1074\/jbc.M111.304758","volume":"287","author":"C Paget","year":"2012","unstructured":"Paget, C. et al. Interleukin-22 Is produced by invariant natural killer T lymphocytes during influenza A virus infection potential role in protection against lung epithelial damages. J. Biol. Chem. 287, 8816\u20138829 (2012).","journal-title":"J. Biol. Chem."},{"key":"10320_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/nri2451","volume":"9","author":"V Cerundolo","year":"2009","unstructured":"Cerundolo, V., Silk, J. D., Masri, S. H. & Salio, M. Harnessing invariant NKT cells in vaccination strategies. Nat. Rev. Immunol. 9, 28\u201338 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"10320_CR26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.4049\/jimmunol.0900389","volume":"184","author":"A Iwata","year":"2010","unstructured":"Iwata, A. et al. Protective roles of B and T lymphocyte attenuator in NKT cell-mediated experimental hepatitis. J. Immunol. 184, 127\u2013133 (2010).","journal-title":"J. Immunol."},{"key":"10320_CR27","doi-asserted-by":"publisher","first-page":"4367","DOI":"10.4049\/jimmunol.165.8.4367","volume":"165","author":"MC Leite-De-Moraes","year":"2000","unstructured":"Leite-De-Moraes, M. C. et al. Fas\/Fas ligand interactions promote activation-induced cell death of NK T lymphocytes. J. Immunol. 165, 4367\u20134371 (2000).","journal-title":"J. Immunol."},{"key":"10320_CR28","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.4049\/jimmunol.175.5.3092","volume":"175","author":"AP Uldrich","year":"2005","unstructured":"Uldrich, A. P. et al. NKT cell stimulation with glycolipid antigen in vivo: costimulation-dependent expansion, Bim-dependent contraction, and hyporesponsiveness to further antigenic challenge. J. Immunol. 175, 3092\u20133101 (2005).","journal-title":"J. Immunol."},{"key":"10320_CR29","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/ni851","volume":"3","author":"MS Vincent","year":"2002","unstructured":"Vincent, M. S. et al. CD1-dependent dendritic cell instruction. Nat. Immunol. 3, 1163\u20131168 (2002).","journal-title":"Nat. Immunol."},{"key":"10320_CR30","doi-asserted-by":"publisher","first-page":"6644","DOI":"10.4049\/jimmunol.0804050","volume":"182","author":"JX Wang","year":"2009","unstructured":"Wang, J. X. et al. Cutting edge: CD28 engagement releases antigen-activated invariant NKT cells from the inhibitory effects of PD-1. J. Immunol. 182, 6644\u20136647 (2009).","journal-title":"J. Immunol."},{"key":"10320_CR31","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1172\/JCI32693","volume":"117","author":"J Zaini","year":"2007","unstructured":"Zaini, J. et al. OX40 ligand expressed by DCs costimulates NKT and CD4+ Th cell antitumor immunity in mice. J. Clin. Investig. 117, 3330\u20133338 (2007).","journal-title":"J. Clin. Investig."},{"key":"10320_CR32","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0016-5085(19)31757-3","volume":"73","author":"JT Horney","year":"1977","unstructured":"Horney, J. T. & Galambos, J. T. The liver during and after fulminant hepatitis. Gastroenterology 73, 639\u2013645 (1977).","journal-title":"Gastroenterology"},{"key":"10320_CR33","first-page":"898","volume":"65","author":"JL Boyer","year":"1976","unstructured":"Boyer, J. L. The diagnosis and pathogenesis of clinical variants in viral hepatitis. Am. J. Clin. Pathol. 65, 898\u2013908 (1976).","journal-title":"Am. J. Clin. Pathol."},{"key":"10320_CR34","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.jhep.2013.02.032","volume":"59","author":"V Kumar","year":"2013","unstructured":"Kumar, V. NKT-cell subsets: Promoters and protectors in inflammatory liver disease. J. Hepatol. 59, 618\u2013620 (2013).","journal-title":"J. Hepatol."},{"key":"10320_CR35","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.4049\/jimmunol.178.3.1293","volume":"178","author":"J Giustiniani","year":"2007","unstructured":"Giustiniani, J., Marie-Cardine, A. & Bensussan, A. A soluble form of the MHC class I-specific CD160 receptor is released from human activated NK lymphocytes and inhibits cell-mediated cytotoxicity. J. Immunol. 178, 1293\u20131300 (2007).","journal-title":"J. Immunol."},{"key":"10320_CR36","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1084\/jem.20131601","volume":"212","author":"TC Tu","year":"2015","unstructured":"Tu, T. C. et al. CD160 is essential for NK-mediated IFN-gamma production. J. Exp. Med. 212, 415\u2013429 (2015).","journal-title":"J. Exp. Med"},{"key":"10320_CR37","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/ni0508-567","volume":"9","author":"GF Cai","year":"2008","unstructured":"Cai, G. F. et al. CD160 inhibits activation of human CD4(+) T cells through interaction with herpesvirus entry mediator (vol 9, pg 176, 2008). Nat. Immunol. 9, 567\u2013567 (2008).","journal-title":"Nat. Immunol."},{"key":"10320_CR38","doi-asserted-by":"publisher","first-page":"27548","DOI":"10.1074\/jbc.273.42.27548","volume":"273","author":"JA Harrop","year":"1998","unstructured":"Harrop, J. A. et al. Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM\/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth. J. Biol. Chem. 273, 27548\u201327556 (1998).","journal-title":"J. Biol. Chem."},{"key":"10320_CR39","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1172\/JCI200522982","volume":"115","author":"Y Wang","year":"2005","unstructured":"Wang, Y. et al. The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses. J. Clin. Investig. 115, 711\u2013717 (2005).","journal-title":"J. Clin. Investig."},{"key":"10320_CR40","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/ni944","volume":"4","author":"N Watanabe","year":"2003","unstructured":"Watanabe, N. et al. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat. Immunol. 4, 670\u2013679 (2003).","journal-title":"Nat. Immunol."},{"key":"10320_CR41","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4049\/jimmunol.0900690","volume":"183","author":"ML Miller","year":"2009","unstructured":"Miller, M. L., Sun, Y. L. & Fu, Y. X. Cutting edge: B and T lymphocyte attenuator signaling on NKT cells inhibits cytokine release and tissue injury in early immune responses. J. Immunol. 183, 32\u201336 (2009).","journal-title":"J. Immunol."},{"key":"10320_CR42","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1172\/JCI200113827","volume":"108","author":"J Wang","year":"2001","unstructured":"Wang, J. et al. The regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHT. J. Clin. Investig. 108, 1771\u20131780 (2001).","journal-title":"J. Clin. Investig."},{"key":"10320_CR43","doi-asserted-by":"publisher","first-page":"4521","DOI":"10.4049\/jimmunol.0802810","volume":"182","author":"C Wahl","year":"2009","unstructured":"Wahl, C., Wegenka, U. M., Leithauser, F., Schirmbeck, R. & Reimann, J. IL-22-dependent attenuation of T cell-dependent (ConA) hepatitis in herpes virus entry mediator deficiency. J. Immunol. 182, 4521\u20134528 (2009).","journal-title":"J. Immunol."},{"key":"10320_CR44","doi-asserted-by":"publisher","first-page":"828","DOI":"10.4049\/jimmunol.1300894","volume":"191","author":"JR Sedy","year":"2013","unstructured":"Sedy, J. R. et al. CD160 activation by herpesvirus entry mediator augments inflammatory cytokine production and cytolytic function by NK cells. J. Immunol. 191, 828\u2013836 (2013).","journal-title":"J. Immunol."},{"key":"10320_CR45","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.immuni.2007.08.017","volume":"27","author":"C Paget","year":"2007","unstructured":"Paget, C. et al. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity 27, 597\u2013609 (2007).","journal-title":"Immunity"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10320-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10320-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10320-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T08:38:02Z","timestamp":1695026282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10320-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,22]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["10320"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-10320-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,22]]},"assertion":[{"value":"23 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3258"}}